Mechanistic analyses have showed that the therapeutic effect of DRD2 signalling in cancer was mediated through the inhibition of the signalling triggered by the vascular endothelial growth factor (VEGF) on endothelial cells [48,51]. This evidence concerns the gene VEGFA and cancer.